Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dienogest for adenomyosis-related pain
CTR20231131Phase 3Completed
- Sponsor
- Shanghai Huilun Pharmaceutical Co., Ltd.
- Start
- Apr 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of dienogest in adenomyosis, sponsored by Shanghai Huilun Pharmaceutical Co., Ltd.. Started Apr 2023; status: completed.
02
Drugs
dienogest
03
Conditions
adenomyosis
Beyond the preview
Go deeper on CTR20231131.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20231131.